Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan outlines the flagship work of the FOCUS4 trials, whose results were presented this weekend at the European Society of Medical Oncology (ESMO) annual meeting

New drug shows promise in slowing growth of bowel cancer

The latest results from the multi-arm FOCUS4 trial, led by Tim Maughan at the University of Oxford, has shown that the drug adavosertib has promising activity in bowel cancer patients